메뉴 건너뛰기




Volumn 12, Issue 4, 2010, Pages 617-627

Optimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters

Author keywords

ABCG2; Glutathione; MRP1; P glycoprotein; Structure activity relationship

Indexed keywords

ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; DOXORUBICIN; DRG 16; DSB 120; ELB 21; GAMMA GLUTAMYLCYSTEINE; GAMMA HISTONE H2AX; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; HISTONE H2AX; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PYRROLO[2,1 C][1,4]BENZODIAZEPINE DERIVATIVE; SG 2003; SG 2781; SG 2796; SG 2797; SG 2819; SG 2820; SG 2823; SG 2825; SG 2897; SG 2900; SG 2901; SG 2902; SJG 136; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE;

EID: 78649683448     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-010-9225-x     Document Type: Article
Times cited : (14)

References (41)
  • 2
    • 0033250545 scopus 로고    scopus 로고
    • Multidrug-resistance transporters
    • 1:CAS:528:DC%2BD3cXkslylurc%3D 10.1007/0-306-46812-3-13 10742982
    • JA Silverman 1999 Multidrug-resistance transporters Pharm Biotechnol 12 353 386 1:CAS:528:DC%2BD3cXkslylurc%3D 10.1007/0-306-46812-3-13 10742982
    • (1999) Pharm Biotechnol , vol.12 , pp. 353-386
    • Silverman, J.A.1
  • 3
    • 34250177984 scopus 로고    scopus 로고
    • The blood-brain barrier and cancer: Transporters, treatment, and trojan horses
    • DOI 10.1158/1078-0432.CCR-06-2854
    • JF Deeken W Loscher 2007 The blood-brain barrier and cancer: transporters, treatment, and Trojan horses Clin Cancer Res 13 6 1663 1674 1:CAS:528:DC%2BD2sXivV2gtrg%3D 10.1158/1078-0432.CCR-06-2854 17363519 (Pubitemid 46952931)
    • (2007) Clinical Cancer Research , vol.13 , Issue.6 , pp. 1663-1674
    • Deeken, J.F.1    Loscher, W.2
  • 4
    • 43449133278 scopus 로고    scopus 로고
    • Resistance to chemotherapy in cancer: A complex and integrated cellular response
    • DOI 10.1159/000115967
    • HR Mellor R Callaghan 2008 Resistance to chemotherapy in cancer: a complex and integrated cellular response Pharmacology 81 4 275 300 1:CAS:528:DC%2BD1cXlsFOgs70%3D 10.1159/000115967 18259091 (Pubitemid 351666917)
    • (2008) Pharmacology , vol.81 , Issue.4 , pp. 275-300
    • Mellor, H.R.1    Callaghan, R.2
  • 6
    • 0035282633 scopus 로고    scopus 로고
    • Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity
    • DOI 10.1021/jm001064n
    • SJ Gregson PW Howard JA Hartley NA Brooks LJ Adams TC Jenkins, et al. 2001 Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity J Med Chem 44 5 737 748 1:CAS:528:DC%2BD3MXmvVOisA%3D%3D 10.1021/jm001064n 11262084 (Pubitemid 32171670)
    • (2001) Journal of Medicinal Chemistry , vol.44 , Issue.5 , pp. 737-748
    • Gregson, S.J.1    Howard, P.W.2    Hartley, J.A.3    Brooks, N.A.4    Adams, L.J.5    Jenkins, T.C.6    Kelland, L.R.7    Thurston, D.E.8
  • 7
    • 77649192721 scopus 로고    scopus 로고
    • A phase i trial of SJG-136 (NSC#694501) in advanced solid tumors
    • 1:CAS:528:DC%2BC3cXit1GmtL0%3D 10.1007/s00280-009-1088-4 19672598
    • YY Janjigian W Lee MG Kris VA Miller LM Krug CG Azzoli, et al. 2010 A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors Cancer Chemother Pharmacol 65 5 833 838 1:CAS:528:DC%2BC3cXit1GmtL0%3D 10.1007/s00280-009-1088-4 19672598
    • (2010) Cancer Chemother Pharmacol , vol.65 , Issue.5 , pp. 833-838
    • Janjigian, Y.Y.1    Lee, W.2    Kris, M.G.3    Miller, V.A.4    Krug, L.M.5    Azzoli, C.G.6
  • 8
    • 4644316457 scopus 로고    scopus 로고
    • SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations
    • DOI 10.1158/0008-5472.CAN-03-2942
    • MC Alley MG Hollingshead CM Pacula-Cox WR Waud JA Hartley PW Howard, et al. 2004 SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluations Cancer Res 64 18 6700 6706 1:CAS:528:DC%2BD2cXnsFOksr0%3D 10.1158/0008-5472.CAN-03-2942 15374987 (Pubitemid 39297933)
    • (2004) Cancer Research , vol.64 , Issue.18 , pp. 6700-6706
    • Alley, M.C.1    Hollingshead, M.G.2    Pacula-Cox, C.M.3    Waud, W.R.4    Hartley, J.A.5    Howard, P.W.6    Gregson, S.J.7    Thurston, D.E.8    Sausville, E.A.9
  • 9
    • 23644457140 scopus 로고    scopus 로고
    • Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136
    • DOI 10.1016/j.ejca.2005.04.026, PII S0959804905004259
    • SM Guichard JS Macpherson DE Thurston DI Jodrell 2005 Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136 Eur J Cancer 41 12 1811 1818 1:CAS:528:DC%2BD2MXns1WitLw%3D 10.1016/j.ejca.2005.04.026 16046116 (Pubitemid 41132645)
    • (2005) European Journal of Cancer , vol.41 , Issue.12 , pp. 1811-1818
    • Guichard, S.M.1    Macpherson, J.S.2    Thurston, D.E.3    Jodrell, D.I.4
  • 10
    • 77950584653 scopus 로고    scopus 로고
    • Structure-activity relationships of monomeric C2-aryl pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) antitumor agents
    • 1:CAS:528:DC%2BC3cXjtVygsLs%3D 10.1021/jm901722v 20218628
    • D Antonow M Kaliszczak GD Kang M Coffils AC Tiberghien N Cooper, et al. 2010 Structure-activity relationships of monomeric C2-aryl pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) antitumor agents J Med Chem 53 7 2927 2941 1:CAS:528:DC%2BC3cXjtVygsLs%3D 10.1021/jm901722v 20218628
    • (2010) J Med Chem , vol.53 , Issue.7 , pp. 2927-2941
    • Antonow, D.1    Kaliszczak, M.2    Kang, G.D.3    Coffils, M.4    Tiberghien, A.C.5    Cooper, N.6
  • 11
    • 33846963786 scopus 로고    scopus 로고
    • Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)
    • 1:CAS:528:DC%2BD2sXislSgsrc%3D 17309854
    • AM Burger PM Loadman DE Thurston R Schultz HH Fiebig MC Bibby 2007 Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119) J Chemother 19 1 66 78 1:CAS:528:DC%2BD2sXislSgsrc%3D 17309854
    • (2007) J Chemother , vol.19 , Issue.1 , pp. 66-78
    • Burger, A.M.1    Loadman, P.M.2    Thurston, D.E.3    Schultz, R.4    Fiebig, H.H.5    Bibby, M.C.6
  • 13
    • 63449133609 scopus 로고    scopus 로고
    • Phase i study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors
    • 1:CAS:528:DC%2BD1MXjtF2rurg%3D 10.1158/1078-0432.CCR-08-1315 19276288
    • D Hochhauser T Meyer VJ Spanswick J Wu PH Clingen P Loadman, et al. 2009 Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors Clin Cancer Res 15 6 2140 2147 1:CAS:528:DC%2BD1MXjtF2rurg%3D 10.1158/1078-0432.CCR-08-1315 19276288
    • (2009) Clin Cancer Res , vol.15 , Issue.6 , pp. 2140-2147
    • Hochhauser, D.1    Meyer, T.2    Spanswick, V.J.3    Wu, J.4    Clingen, P.H.5    Loadman, P.6
  • 14
    • 34249935509 scopus 로고    scopus 로고
    • Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library
    • 1:CAS:528:DC%2BD2sXjs1Sktb0%3D 10.1021/cc0601332 17397227
    • D Antonow N Cooper PW Howard DE Thurston 2007 Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library J Comb Chem 9 3 437 445 1:CAS:528:DC%2BD2sXjs1Sktb0%3D 10.1021/cc0601332 17397227
    • (2007) J Comb Chem , vol.9 , Issue.3 , pp. 437-445
    • Antonow, D.1    Cooper, N.2    Howard, P.W.3    Thurston, D.E.4
  • 15
    • 0035814023 scopus 로고    scopus 로고
    • Synthesis of the first example of a C2-C3/C2'-C3'-endo unsaturated pyrrolo[2, 1-c][1, 4]benzodiazepine dimer
    • 1:CAS:528:DC%2BD3MXnsVKls7w%3D 10.1016/S0960-894X(01)00560-1 11597416
    • SJ Gregson PW Howard KE Corcoran TC Jenkins LR Kelland DE Thurston 2001 Synthesis of the first example of a C2-C3/C2'-C3'-endo unsaturated pyrrolo[2, 1-c][1, 4]benzodiazepine dimer Bioorg Med Chem Lett 11 21 2859 2862 1:CAS:528:DC%2BD3MXnsVKls7w%3D 10.1016/S0960-894X(01)00560-1 11597416
    • (2001) Bioorg Med Chem Lett , vol.11 , Issue.21 , pp. 2859-2862
    • Gregson, S.J.1    Howard, P.W.2    Corcoran, K.E.3    Jenkins, T.C.4    Kelland, L.R.5    Thurston, D.E.6
  • 16
    • 0021815179 scopus 로고
    • Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine
    • 1:CAS:528:DyaL2MXktF2itb8%3D 3986765
    • KG Louie BC Behrens TJ Kinsella TC Hamilton KR Grotzinger WM McKoy, et al. 1985 Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine Cancer Res 45 5 2110 2115 1:CAS:528:DyaL2MXktF2itb8%3D 3986765
    • (1985) Cancer Res , vol.45 , Issue.5 , pp. 2110-2115
    • Louie, K.G.1    Behrens, B.C.2    Kinsella, T.J.3    Hamilton, T.C.4    Grotzinger, K.R.5    McKoy, W.M.6
  • 17
    • 0026496549 scopus 로고
    • Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells
    • 1:CAS:528:DyaK3sXjt1KgtQ%3D%3D 1358431
    • M Nakagawa E Schneider KH Dixon J Horton K Kelley C Morrow, et al. 1992 Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells Cancer Res 52 22 6175 6181 1:CAS:528:DyaK3sXjt1KgtQ%3D%3D 1358431
    • (1992) Cancer Res , vol.52 , Issue.22 , pp. 6175-6181
    • Nakagawa, M.1    Schneider, E.2    Dixon, K.H.3    Horton, J.4    Kelley, K.5    Morrow, C.6
  • 18
    • 0025341331 scopus 로고
    • New colorimetric cytotoxicity assay for anticancer-drug screening
    • 1:CAS:528:DyaK3cXltVylsL8%3D 10.1093/jnci/82.13.1107 2359136
    • P Skehan R Storeng D Scudiero A Monks J McMahon D Vistica, et al. 1990 New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 13 1107 1112 1:CAS:528:DyaK3cXltVylsL8%3D 10.1093/jnci/82.13.1107 2359136
    • (1990) J Natl Cancer Inst , vol.82 , Issue.13 , pp. 1107-1112
    • Skehan, P.1    Storeng, R.2    Scudiero, D.3    Monks, A.4    McMahon, J.5    Vistica, D.6
  • 19
    • 0025804183 scopus 로고
    • Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
    • 1:CAS:528:DyaK3MXhslOrt7c%3D 10.1016/0006-291X(91)91647-U 1673839
    • P Artursson J Karlsson 1991 Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem Biophys Res Commun 175 3 880 885 1:CAS:528:DyaK3MXhslOrt7c%3D 10.1016/0006-291X(91)91647-U 1673839
    • (1991) Biochem Biophys Res Commun , vol.175 , Issue.3 , pp. 880-885
    • Artursson, P.1    Karlsson, J.2
  • 21
    • 0024593744 scopus 로고
    • Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
    • 1:STN:280:DyaL1M7itFeqsg%3D%3D 2914637
    • IJ Hidalgo TJ Raub RT Borchardt 1989 Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 3 736 749 1:STN:280:DyaL1M7itFeqsg%3D%3D 2914637
    • (1989) Gastroenterology , vol.96 , Issue.3 , pp. 736-749
    • Hidalgo, I.J.1    Raub, T.J.2    Borchardt, R.T.3
  • 24
    • 0032518454 scopus 로고    scopus 로고
    • A general pattern for substrate recognition by P-glycoprotein
    • DOI 10.1046/j.1432-1327.1998.2510252.x
    • A Seelig 1998 A general pattern for substrate recognition by P-glycoprotein Eur J Biochem 251 1-2 252 261 1:CAS:528:DyaK1cXnvV2rsg%3D%3D 10.1046/j.1432-1327.1998.2510252.x 9492291 (Pubitemid 28081437)
    • (1998) European Journal of Biochemistry , vol.251 , Issue.1-2 , pp. 252-261
    • Seelig, A.1
  • 26
    • 0022870696 scopus 로고
    • Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells
    • 1:CAS:528:DyaL2sXktFOgtb0%3D 10.1007/BF00173503 3583642
    • RT Dorr JD Liddil MJ Soble 1986 Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells Invest New Drugs 4 4 305 313 1:CAS:528:DyaL2sXktFOgtb0%3D 10.1007/BF00173503 3583642
    • (1986) Invest New Drugs , vol.4 , Issue.4 , pp. 305-313
    • Dorr, R.T.1    Liddil, J.D.2    Soble, M.J.3
  • 27
    • 1842535990 scopus 로고    scopus 로고
    • Classification analysis of P-glycoprotein substrate specificity
    • DOI 10.1080/10611860310001648248
    • R Didziapetris P Japertas A Avdeef A Petrauskas 2003 Classification analysis of P-glycoprotein substrate specificity J Drug Target 11 7 391 406 1:CAS:528:DC%2BD2cXjtFOjs7k%3D 10.1080/10611860310001648248 15203928 (Pubitemid 38455825)
    • (2003) Journal of Drug Targeting , vol.11 , Issue.7 , pp. 391-406
    • Didziapetris, R.1    Japertas, P.2    Avdeef, A.3    Petrauskas, A.4
  • 28
    • 0028030228 scopus 로고
    • Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
    • 1:CAS:528:DyaK2MXitVantbw%3D 7969041
    • JS Lee K Paull M Alvarez C Hose A Monks M Grever, et al. 1994 Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen Mol Pharmacol 46 4 627 638 1:CAS:528:DyaK2MXitVantbw%3D 7969041
    • (1994) Mol Pharmacol , vol.46 , Issue.4 , pp. 627-638
    • Lee, J.S.1    Paull, K.2    Alvarez, M.3    Hose, C.4    Monks, A.5    Grever, M.6
  • 29
    • 0343306779 scopus 로고    scopus 로고
    • Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein
    • DOI 10.1021/bi9718043
    • M Essodaigui HJ Broxterman A Garnier-Suillerot 1998 Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein Biochemistry 37 8 2243 2250 1:CAS:528:DyaK1cXotFGmtw%3D%3D 10.1021/bi9718043 9485370 (Pubitemid 28119297)
    • (1998) Biochemistry , vol.37 , Issue.8 , pp. 2243-2250
    • Essodaigui, M.1    Broxterman, H.J.2    Garnier-Suillerot, A.3
  • 30
    • 0033739115 scopus 로고    scopus 로고
    • Structure-activity relationship of P-glycoprotein substrates and modifiers
    • 1:CAS:528:DC%2BD3cXot1yiu7w%3D 10.1016/S0928-0987(00)00177-9 11121731
    • A Seelig E Landwojtowicz 2000 Structure-activity relationship of P-glycoprotein substrates and modifiers Eur J Pharm Sci 12 1 31 40 1:CAS:528:DC%2BD3cXot1yiu7w%3D 10.1016/S0928-0987(00)00177-9 11121731
    • (2000) Eur J Pharm Sci , vol.12 , Issue.1 , pp. 31-40
    • Seelig, A.1    Landwojtowicz, E.2
  • 31
    • 0033669437 scopus 로고    scopus 로고
    • Prediction of drug transport processes using simple parameters and PLS statistics. the use of ACD/logP and ACD/ChemSketch descriptors
    • 1:CAS:528:DC%2BD3cXoslGhtbk%3D 10.1016/S0928-0987(00)00189-5 11113652
    • T Osterberg U Norinder 2001 Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors Eur J Pharm Sci 12 3 327 337 1:CAS:528:DC%2BD3cXoslGhtbk%3D 10.1016/S0928-0987(00)00189-5 11113652
    • (2001) Eur J Pharm Sci , vol.12 , Issue.3 , pp. 327-337
    • Osterberg, T.1    Norinder, U.2
  • 32
    • 14644419054 scopus 로고    scopus 로고
    • Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein mediated efflux transport
    • DOI 10.1021/mp0499196
    • MV Varma K Sateesh R Panchagnula 2005 Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport Mol Pharmacol 2 1 12 21 1:CAS:528:DC%2BD2cXhtVSmu7vF 10.1021/mp0499196 (Pubitemid 40314725)
    • (2005) Molecular Pharmaceutics , vol.2 , Issue.1 , pp. 12-21
    • Varma, M.V.S.1    Sateesh, K.2    Panchagnula, R.3
  • 33
    • 29244485123 scopus 로고    scopus 로고
    • Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse
    • DOI 10.1016/j.ejps.2005.09.009, PII S0928098705002824
    • S Vautier L Lacomblez H Chacun V Picard F Gimenez R Farinotti, et al. 2006 Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse Eur J Pharm Sci 27 2-3 167 174 1:CAS:528:DC%2BD2MXhtlCktbfP 10.1016/j.ejps.2005.09.009 16263252 (Pubitemid 41831252)
    • (2006) European Journal of Pharmaceutical Sciences , vol.27 , Issue.2-3 , pp. 167-174
    • Vautier, S.1    Lacomblez, L.2    Chacun, H.3    Picard, V.4    Gimenez, F.5    Farinotti, R.6    Fernandez, C.7
  • 35
    • 0031936939 scopus 로고    scopus 로고
    • Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin
    • 1:CAS:528:DyaK1cXhtlSmsbs%3D 9516927
    • E Mechetner A Kyshtoobayeva S Zonis H Kim R Stroup R Garcia, et al. 1998 Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin Clin Cancer Res 4 2 389 398 1:CAS:528:DyaK1cXhtlSmsbs%3D 9516927
    • (1998) Clin Cancer Res , vol.4 , Issue.2 , pp. 389-398
    • Mechetner, E.1    Kyshtoobayeva, A.2    Zonis, S.3    Kim, H.4    Stroup, R.5    Garcia, R.6
  • 36
    • 33644755350 scopus 로고    scopus 로고
    • Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer
    • DOI 10.1016/j.canlet.2005.05.052, PII S0304383505009286, Pharmacogenomics in Cancer Chemotherapy: Recent Advances in Drug Transporters and Genome Analysis
    • H Nakagawa H Saito Y Ikegami S Aida-Hyugaji S Sawada T Ishikawa 2006 Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer Cancer Lett 234 1 81 89 1:CAS:528:DC%2BD28Xit12itb8%3D 10.1016/j.canlet.2005.05.052 16309825 (Pubitemid 43343942)
    • (2006) Cancer Letters , vol.234 , Issue.1 , pp. 81-89
    • Nakagawa, H.1    Saito, H.2    Ikegami, Y.3    Aida-Hyugaji, S.4    Sawada, S.5    Ishikawa, T.6
  • 37
    • 33750478648 scopus 로고    scopus 로고
    • Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
    • DOI 10.1038/sj.bjp.0706904, PII 0706904
    • R Clark ID Kerr R Callaghan 2006 Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter Br J Pharmacol 149 5 506 515 1:CAS:528:DC%2BD28XhtFeru7vO 10.1038/sj.bjp.0706904 16981002 (Pubitemid 44658511)
    • (2006) British Journal of Pharmacology , vol.149 , Issue.5 , pp. 506-515
    • Clark, R.1    Kerr, I.D.2    Callaghan, R.3
  • 38
    • 22244441801 scopus 로고    scopus 로고
    • Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501)
    • 1:CAS:528:DC%2BD2MXmsVOnurY%3D 15994138
    • A Cheung E Struble J He C Yang E Wang DE Thurston, et al. 2005 Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501) J Chromatogr B Analyt Technol Biomed Life Sci 822 1-2 10 20 1:CAS:528: DC%2BD2MXmsVOnurY%3D 15994138
    • (2005) J Chromatogr B Analyt Technol Biomed Life Sci , vol.822 , Issue.12 , pp. 10-20
    • Cheung, A.1    Struble, E.2    He, J.3    Yang, C.4    Wang, E.5    Thurston, D.E.6
  • 39
    • 0036644903 scopus 로고    scopus 로고
    • Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918
    • DOI 10.1200/JCO.2002.12.116
    • CM Kruijtzer JH Beijnen H Rosing 2002 ten Bokkel Huinink WW, Schot M, Jewell RC, et al. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918 J Clin Oncol 20 13 2943 2950 1:CAS:528:DC%2BD38Xlslyrt7w%3D 10.1200/JCO.2002.12. 116 12089223 (Pubitemid 34728888)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.13 , pp. 2943-2950
    • Kruijtzer, C.M.F.1    Beijnen, J.H.2    Rosing, H.3    Ten Bokkel Huinink, W.W.4    Schot, M.5    Jewell, R.C.6    Paul, E.M.7    Schellens, J.H.M.8
  • 40
    • 0035992230 scopus 로고    scopus 로고
    • Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase i clinical study
    • 1:CAS:528:DC%2BD38XmtVWit7s%3D 12114401
    • HM McDaid S Mani HJ Shen F Muggia D Sonnichsen SB Horwitz 2002 Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study Clin Cancer Res 8 7 2035 2043 1:CAS:528: DC%2BD38XmtVWit7s%3D 12114401
    • (2002) Clin Cancer Res , vol.8 , Issue.7 , pp. 2035-2043
    • McDaid, H.M.1    Mani, S.2    Shen, H.J.3    Muggia, F.4    Sonnichsen, D.5    Horwitz, S.B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.